Even though the identification of conolidine as a potential novel analgesic agent presents an extra avenue to address the opioid crisis and handle CNCP, further reports are required to grasp its mechanism of action and utility and efficacy in running CNCP.GDR Labs Conolidine Drops represent a breakthrough in the field of discomfort management, offe